Literature DB >> 26416866

Fluoroquinolone Impact on Nasal Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Colonization Durations in Neurologic Long-Term-Care Facilities.

Clotilde Couderc1, Anne C M Thiébaut2, Christine Lawrence3, Coralie Bouchiat4, Jean-Louis Herrmann5, Jérôme Salomon6, Didier Guillemot7.   

Abstract

Staphylococcus aureus nasal carriage is a risk factor for subsequent infection. Estimates of colonization duration vary widely among studies, and factors influencing the time to loss of colonization, especially the impact of antibiotics, remain unclear. We conducted a prospective study on patients naive for S. aureus colonization in 4 French long-term-care facilities. Data on nasal colonization status and potential factors for loss of colonization were collected weekly. We estimated methicillin-resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) colonization durations using the Kaplan-Meier method and investigated factors for loss of colonization using shared-frailty Cox proportional hazards models. A total of 285 S. aureus colonization episodes were identified in 149 patients. The median time to loss of MRSA or MSSA colonization was 3 weeks (95% confidence interval, 2 to 8 weeks) or 2 weeks (95% confidence interval, 2 to 3 weeks), respectively. In multivariable analyses, the methicillin resistance phenotype was not associated with S. aureus colonization duration (P = 0.21); the use of fluoroquinolones (hazard ratio, 3.37; 95% confidence interval, 1.31 to 8.71) and having a wound positive for a nonnasal strain (hazard ratio, 2.17; 95% confidence interval, 1.15 to 4.07) were associated with earlier loss of MSSA colonization, while no factor was associated with loss of MRSA colonization. These results suggest that the methicillin resistance phenotype does not influence the S. aureus colonization duration and that fluoroquinolones are associated with loss of MSSA colonization but not with loss of MRSA colonization.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26416866      PMCID: PMC4649197          DOI: 10.1128/AAC.01338-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Healthy carriage of Staphylococcus aureus: its prevalence and importance.

Authors:  R E WILLIAMS
Journal:  Bacteriol Rev       Date:  1963-03

2.  Duration of colonization with methicillin-resistant Staphylococcus aureus.

Authors:  Ari Robicsek; Jennifer L Beaumont; Lance R Peterson
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

3.  Methicillin-resistant Staphylococcus aureus carriage among patients after hospital discharge.

Authors:  Menno R Vriens; Hetty E M Blok; Ada C M Gigengack-Baars; Ellen M Mascini; Chris van der Werken; Jan Verhoef; Annet Troelstra
Journal:  Infect Control Hosp Epidemiol       Date:  2005-07       Impact factor: 3.254

4.  Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus.

Authors:  M D Sanford; A F Widmer; M J Bale; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

5.  Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

Authors:  C von Eiff; K Becker; K Machka; H Stammer; G Peters
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

Review 6.  The role of nasal carriage in Staphylococcus aureus infections.

Authors:  Heiman F L Wertheim; Damian C Melles; Margreet C Vos; Willem van Leeuwen; Alex van Belkum; Henri A Verbrugh; Jan L Nouwen
Journal:  Lancet Infect Dis       Date:  2005-12       Impact factor: 25.071

7.  Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares.

Authors:  M Dall'Antonia; P G Coen; M Wilks; A Whiley; M Millar
Journal:  J Hosp Infect       Date:  2005-09       Impact factor: 3.926

8.  Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition.

Authors:  Jonas Marschall; Kathrin Mühlemann
Journal:  Infect Control Hosp Epidemiol       Date:  2006-10-04       Impact factor: 3.254

9.  Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections.

Authors:  Jan L Nouwen; Marien W J A Fieren; Susan Snijders; Henri A Verbrugh; Alex van Belkum
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

10.  Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers.

Authors:  Rupak Datta; Susan S Huang
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.